Breast Cancer Prevention: Aromatase Inhibitors American Cancer Society
Breast Cancer Prevention: Aromatase Inhibitors American Cancer Society This hypothesis could be tested by collecting tissues from patients recurring on nonsteroidal AIs and measuring levels of aromatase mRNA, protein, and activity. Aromatase inhibitors (AIs) are approved for use in both early- and advanced-stage breast cancer in postmenopausal women. Although the currently approved “third-generation” AIs all […]
Breast Cancer Prevention: Aromatase Inhibitors American Cancer Society Read More »